Image

Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients

Investigating How Well an Investigational Medication Works in Metastatic Pancreatic Cancer

Recruiting
21-99 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates metastatic pancreatic cancer. The purpose is to explore the effects of a specific treatment regimen on this condition.

The study evaluates the safety and effectiveness of a treatment approach using a combination of medications. It focuses on understanding how well patients tolerate the regimen and its impact on the condition.

  • Who can participate: Adults over 21 with advanced pancreatic cancer are eligible. Participants must have measurable disease and meet health criteria, including specific blood, liver, and kidney function levels.
  • Study details: Participants will receive the investigational treatment at the National Cancer Centre, Singapore.
Print
Study details
    Metastatic Pancreatic Cancer

NCT05929885

National Cancer Centre, Singapore

30 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.